Igc Pharma Is A Clinical Stage Pharmaceutical Company Based In Potomacmarylandfocused On Developing Innovative Treatments For Alzheimer S Diseasefounded In 2005 And Rebranded In March 2023The Company Employs Around 67 People Under Ceo Ram Mukundaigc Pharma Aims To Create Accessible Therapies That Improve The Quality Of Life For Patients And Their Families The Company Is Engaged In Research And Development Of Drug Candidates Targeting Various Aspects Of Alzheimer S Diseaseincluding Neuroinflammation And Amyloid Beta Plaquestheir Product Pipeline Features Several Investigational Drugssuch As Igc Ad1Which Is In A Phase 2B Clinical Trial To Address Agitation In Dementiaand Tgr 63Aimed At Halting Disease Progressionother Candidates In Development Focus On Inhibiting Amyloid Beta Aggregation And Targeting Tau Protein Igc Pharma Is Committed To Affordability And Accessibilityensuring That Their Treatments Reach A Global Patient Populationincluding Underserved Regionsin Addition To Its Pharmaceutical Effortsthe Company Also Has A Segment Involved In Construction Contracts And Heavy Equipment Rental
